CLINICAL_TRIALS
research
· 2025-02-25
Clinical Trial Update: The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure [Phase 1, Phase 2]
Summary
A Phase 1/Phase 2 clinical trial assessing the safety, tolerability, and preliminary efficacy of HepaCure in Chinese patients with acute-on-chronic liver failur…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hexaell Biotech Co., Ltd. | Conditions: Acute on Chronic Hepatic Failure, Liver Failure | Phase 1, Phase 2 | Status: RECRUITING